Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.90335 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.80263 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.8175 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.7403 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.72307 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.0811 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.91821 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.78923 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.89606 | 65 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.90522 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.79975 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.7433 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.80705 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.81117 | 64 |